Iovance Biotherapeutics Inc. buy Wells Fargo & Company
Start price
08.08.25
/
50%
€1.87
Target price
08.08.26
€12.01
Performance (%)
121.31%
Price
28.07.26
€4.14
Summary
This prediction is currently active. With a performance of 121.31% the BUY prediction by Wells_Fargo___Compan is a big success. This prediction currently runs until 08.08.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Iovance Biotherapeutics Inc. | -13.944% | -13.944% |
| iShares Core DAX® | 1.717% | 3.368% |
| iShares Nasdaq 100 | -4.565% | -4.238% |
| iShares Nikkei 225® | -7.120% | -11.869% |
| iShares S&P 500 | -0.894% | 1.687% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Iovance Biotherapeutics Inc. diskutieren
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target lowered by analysts at Wells Fargo & Company from $18.00 to $14.00. They now have an "overweight" rating on the stock.
Ratings data for IOVA provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€11.70
20.02.24
20.02.24
€20.35
20.02.25
20.02.25
-52.82%
21.02.25
21.02.25
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€7.97
30.05.23
30.05.23
€15.85
30.05.24
30.05.24
4.72%
31.05.24
31.05.24